Laboratório de Pesquisas Clínicas e Experimentais em Biologia Vascular, Centro Biomédico, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Clin Hemorheol Microcirc. 2021;77(4):443-459. doi: 10.3233/CH-201019.
Protective effects of Ruscus extract on macromolecular permeability depend on its capacity to stimulate muscarinic receptors on endothelial cells and induce the release of endothelium derived relaxing factors (EDRFs).
To investigate if these effects depend only on activation of muscarinic receptors or if EDRFs release are also necessary. We have also investigated the participation of Ruscus extract on muscarinic-induced release of EDRFs on microvascular diameters.
Hamsters were treated daily during two weeks with Ruscus extract (50, 150 and 450 mg/kg/day) and then macromolecular permeability induced by histamine and arteriolar and venular diameters after cyclooxygenase (COX) and nitric oxide synthase (NOS) inhibitors: indomethacin and Nω-Nitro-L-arginine (LNA), respectively applied topically at 10-8M, 10-6M and 10-4M were observed on the cheek pouch preparation.
Ruscus extract decreased macromolecular permeability in a dose-dependent fashion and did not affect microvascular diameters. NOS and COX inhibitors enhanced its effect on microvascular permeability. NOS inhibition reduced arteriolar diameter and COX blocking decreased arteriolar and venular diameters at the lowest dose and increased them at higher doses of Ruscus extract.
The protective effect of Ruscus extract on macromolecular permeability seems to be mediated only via muscarinic receptors. Muscarinic activation attenuated vasoconstrictive tone through cyclooxygenase-independent endothelium derived relaxing factors.
菝葜提取物对大分子通透性的保护作用取决于其刺激内皮细胞毒蕈碱受体和诱导内皮衍生松弛因子(EDRFs)释放的能力。
研究这些作用是否仅依赖于毒蕈碱受体的激活,或者 EDRFs 的释放是否也是必需的。我们还研究了菝葜提取物对微血管直径上的毒蕈碱诱导 EDRFs 释放的影响。
在两周内,每天用菝葜提取物(50、150 和 450mg/kg/天)处理仓鼠,然后用组胺诱导大分子通透性,并在颊囊制剂上用环氧化酶(COX)和一氧化氮合酶(NOS)抑制剂局部应用 10-8M、10-6M 和 10-4M 的吲哚美辛和 Nω-硝基-L-精氨酸(LNA)观察小动脉和小静脉直径。
菝葜提取物以剂量依赖的方式降低大分子通透性,不影响微血管直径。NOS 和 COX 抑制剂增强了其对微血管通透性的作用。NOS 抑制降低了小动脉直径,COX 阻断在菝葜提取物的最低剂量下降低了小动脉和小静脉直径,在较高剂量下增加了它们的直径。
菝葜提取物对大分子通透性的保护作用似乎仅通过毒蕈碱受体介导。毒蕈碱受体激活通过非 COX 依赖性内皮衍生松弛因子减轻血管收缩紧张。